Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The granulocyte colony-stimulating factor receptor (G-CSFR), also known as CSF3R, is a cell surface receptor primarily expressed on precursor cells in the bone marrow. It mediates the effects of its ligand, granulocyte colony-stimulating factor (G-CSF), to stimulate proliferation and differentiation of myeloid progenitors into mature neutrophilic granulocytes and macrophages. Upon activation by G-CSF, G-CSFR initiates multiple intracellular signaling cascades, including JAK/STAT, PI3K-AKT, and RAS-MAPK pathways.
Recombinant human G-CSF binds to the G-CSFR, stimulating proliferation and differentiation of myeloid progenitors into mature neutrophils.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Granulocyte colony-stimulating factor receptor (None).